Evaluating the Role of Biosimilars in the Management of Rheumatologic Conditions

Download All
In these downloadable slidesets, our expert faculty members Stanley B. Cohen, MD; Jonathan Kay, MD; and Kenneth G. Saag, MD, MSc, explore the expanding role of biosimilars in the management of rheumatologic conditions.
Stanley B. Cohen, MD
Jonathan Kay, MD
Kenneth G. Saag, MD, MSc

Downloadable Slidesets

In this downloadable slideset, Stanley B. Cohen, MD, reviews the regulatory pathway and development of biosimilars.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Released: November 21, 2017

In this downloadable slideset, Jonathan Kay, MD, explores key concepts including immunogenicity, switching, and interchangeability of biosimilars.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Released: November 21, 2017

In this downloadable slideset, Kenneth G. Saag, MD, MSc, reviews the evidence supporting currently FDA-approved biosimilars.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Released: November 15, 2017

The Biosimilars Quiz Game: Evaluating the Role of Biosimilars in the Management of Rheumatologic Conditions

Watch our recent quiz game on biosimilars in rheumatologic conditions.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: November 28, 2017 Expired: No longer available for credit
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
PIM Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by independent educational grants from
Boehringer Ingelheim Pharmaceuticals, Inc.
Sandoz Inc., a Novartis Division

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings